Jun. 11 at 5:39 PM
$AVDE $NVO
Under the terms of the deal, valued at up to
$812 million, Deep Apple will discover oral therapies using its AI-based drug discovery platform, and Novo Nordisk will receive exclusive global rights to develop, manufacture, and commercialize the resulting compounds and products in all indications.